A new national survey of centers for cognitive disorders and dementias in Italy

Neurological Sciences - Trang 1-14 - 2023
Ilaria Bacigalupo1, Francesco Giaquinto2, Emanuela Salvi3, Giulia Carnevale4, Roberta Vaccaro4,5, Fabio Matascioli4,6, Giulia Remoli7, Nicola Vanacore1, Patrizia Lorenzini1
1National Centre for Disease Prevention and Health Promotion, Italian National Institute of Health, Rome, Italy
2Department of Human and Social Sciences, University of Salento, Lecce, Italy
3National Center for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy
4Italian National Institute of Health FONDEM Study Group, Rome, Italy
5GINCO, Aware Aging Group, Como, Italy
6TAM Onlus, Social Cooperative, Naples, Italy
7Neurology Section, University of Milano-Bicocca, Milan, Italy

Tóm tắt

A new national survey has been carried out by the Italian Centers for Cognitive Disorders and Dementias (CCDDs). The aim of this new national survey is to provide a comprehensive description of the characteristics, organizational aspects of the CCDDs, and experiences during the COVID-19 pandemic. A list of all national CCDDs was requested from the delegates of each Italian region. The online questionnaire is divided in two main sections: a profile section, containing information on location and accessibility, and a data collection form covering organization, services, treatments, activities, and any service interruptions caused by the COVID-19 outbreak. In total, 511 out of 534 (96%) facilities completed the profile section, while 450 out of 534 (84%) CCDDs also completed the data collection form. Almost half of the CCDDs (55.1%) operated for 3 or fewer days a week. About one-third of the facilities had at least two professional figures among neurologists, geriatricians and psychiatrists. In 2020, only a third of facilities were open all the time, but in 2021, two-thirds of the facilities were open. This paper provides an update on the current status of CCDDs in Italy, which still shows considerable heterogeneity. The survey revealed a modest improvement in the functioning of CCDDs, although substantial efforts are still required to ensure the diagnosis and care of patients with dementia.

Tài liệu tham khảo

Global action plan on the public health response to dementia 2017–2025. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO 1. https://www.who.int/publications/i/item/global-action-plan-on-the-public-health-response-to-dementia-2017---2025. Accessed 26 April 2023 Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M, Di Fiandra T, Vanacore N (2018) A systematic review and meta-analysis on the prevalence of dementia inEurope: estimates from the highest-quality studies adopting the DSM IV diagnostic criteria. J Alzheimers Dis 66(4):1471–1481. https://doi.org/10.3233/JAD-180416. Sachdev PS, Lipnicki DM, Kochan NA, Crawford JD, Thalamuthu A, Andrews G, Brayne C, Matthews FE, et al. Cohort Studies of Memory in an International Consortium (COSMIC) (2015) The prevalence of mild cognitive impairment in diverse geographical and ethnocultural regions: the COSMIC Collaboration. PloS One 10(11):e0142388. https://doi.org/10.1371/journal.pone.0142388 Mayer F, Remoli G, Bacigalupo I, Palazzesi I, Piscopo P, Bellomo G, Canevelli M, Corbo M, Vanacore N, Lacorte E (2021) Decreasing trend in the incidence and prevalence of dementia: a systematic review. Minerva Med 112(4):430–440. https://doi.org/10.23736/S0026-4806.21.07454-1. Dementia in Europe yearbook 2019: estimating the prevalence of dementia in Europe. https://www.alzheimer-europe.org/resources/publications/dementia-europe-yearbook-2019-estimating-prevalence-dementia-europe. Accessed 26 April 2023 Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396(10248):413–446. https://doi.org/10.1016/S0140-6736(20)30367-6. Gauthier S, Rosa-Neto P, Morais JA, & Webster C. (2021) World Alzheimer Report 2021, Abridged version: journey through the diagnosis of dementia. London, England: Alzheimer’s Disease International. https://www.alzint.org/u/World-Alzheimer-Report-2021.pdf. Accessed 26 April 2023 Steiner GZ, Ee C, Dubois S, MacMillan F, George ES, McBride KA, Karamacoska D, McDonald K, Harley A et al (2020) “We need a one-stop-shop”: co-creating the model of care for a multidisciplinary memory clinic with community members, GPs, aged care workers, service providers, and policy-makers. BMC Geriatr 20(1):49. https://doi.org/10.1186/s12877-019-1410-x. Banerjee S, Wittenberg R (2009) Clinical and cost effectiveness of services for early diagnosis and intervention in dementia. Int J Geriatr Psychiatry 24(7):748–54. https://doi.org/10.1002/gps.2191. Mehrani I, Kochan NA, Ong MY, Crawford JD, Naismith SL, Sachdev PS (2021) Organisational aspects and assessment practices of Australian memory clinics: an Australian Dementia Network (ADNeT) Survey. BMJ Open 11(2):e038624. https://doi.org/10.1136/bmjopen-2020-038624. Birkeland RW, McCarron HR, Nkimberg M, Gaugler JE (2022) Exploring memory care clinics in minnesota: a qualitative analysis. J Geriatr Psychiatry Neurol 35(4):601–612. https://doi.org/10.1177/08919887211044752. Cahill S, Pierce M, Moore V (2014) A national survey of memory clinics in the Republic of Ireland. Int Psychogeriatr 26(4):605–13. https://doi.org/10.1017/S104161021300238X. Gruters AAA, Ramakers IHGB, Kessels RPC, Bouwman FH, Olde Rikkert MGM, Blom MM, de Vugt ME, Verhey FRJ (2019) Development of memory clinics in the Netherlands over the last 20 years. Int J Geriatr Psychiatry 34(8):1267–1274. https://doi.org/10.1002/gps.5132. Stone C, Copeland B, Collier C, Cheung G (2019) Memory clinic survey in New Zealand: a second look. Australas Psychiatry 27(5):486–490. https://doi.org/10.1177/1039856219852299. Werner P, Goldstein D, Heinik J (2009) The process and organizational characteristics of memory clinics in Israel in 2007. Arch Gerontol Geriatr Sep-Oct 49(2):e115–e120. https://doi.org/10.1016/j.archger.2008.10.008. Renewing-priority-for-dementia-Where-do-we-stand-2018.pdf (oecd.org). https://www.oecd.org/health/health-systems/Renewing-priority-for-dementia-Where-do-we-stand-2018.pdf. Accessed 26 April 2023 Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, Taghva K (2022) Alzheimer’s disease drug development pipeline: 2022. Alzheimers Dement (N Y) 8(1):e12295. https://doi.org/10.1002/trc2.12295. 2023 Alzheimer’s disease facts and figures (2023) Alzheimer's Dement. J Alzheimer's Association 19(4):1598–1695. https://doi.org/10.1002/alz.13016. Hlavka JP, Mattke S, Liu JL (2019) Assessing the preparedness of the health care system infrastructure in six European countries for an Alzheimer’s treatment. Rand Health Q 8(3):2 Royal College of Psychiatrists (2022) National audit of dementia - memory assessment service spotlight audit 2021. London: Healthcare Quality Improvement Partnership. Available from: https://www.rcpsych.ac.uk/improving-care/ccqi/national-clinical-audits/national-audit-of-dementia/fifth-round-of-audit/memory-services-spotlight-audit-national-report. Accessed 26 April 2023 Spalletta G, Porcari DE, Banaj N, Ciullo V, Palmer K (2020) Effects of COVID-19 infection control measures on appointment cancelation in an italian outpatient memory clinic. Front Psychiatry 11:599844. https://doi.org/10.3389/fpsyt.2020.599844. Government of Italy. Protocollo di monitoraggio dei piani di trattamento farmacologico per la malattia di Alzheimer. D M July 20, 2000. Gazzetta Ufficiale della Repubblica Italiana n. 204, 1 Settembre 2000. https://www.gazzettaufficiale.it/eli/id/2000/09/01/00A11304/sg. Accessed 26 April 2023 Di Fiandra T, Canevelli M, Di Pucchio A, Vanacore N, Italian Dementia National Plan Working Group (2015) The Italian dementia national plan. Commentary Ann Ist Super Sanità 51:261–264. https://doi.org/10.4415/ANN_15_04_02. https://www.aifa.gov.it/nota-85. Accessed 26 april 2023, Ancidoni A, Sciancalepore F, Bacigalupo I, Bellomo G, Canevelli M, Lacorte E, Lombardo FL, Lorenzini P, Palazzesi I, Permanent Table of the National Dementia Plan Study Group; Istituto Superiore di Sanità FONDEM Study Group; Istituto Superiore di Sanità FONDEM StudyGroup et al (2022) The Italian fund for Alzheimer’s and other dementias: strategies and objectives to face the dementia challenge. Ann Ist Super Sanita 58(3):192–196. https://doi.org/10.4415/ANN_22_03_08. Di Pucchio A, Di Fiandra T, Marzolini F, Lacorte E; SQoDS Group; Vanacore N (2017) Survey of health and social-health services for people with dementia: methodology of the Italian national project. Ann Ist Super Sanita Jul-Sep 53(3):246–252. https://doi.org/10.4415/ANN_17_03_11. Canevelli M, Di Pucchio A, Marzolini F, Mayer F, Massari M, Salvi E, Palazzesi I, Lacorte E et al (2021) A national survey of centers for cognitive disorders and dementias in Italy. J Alzheimers Dis 83(4):1849–1857. https://doi.org/10.3233/JAD-210634. Di Pucchio A, Vanacore N, Marzolini F, Lacorte E, Di Fiandra T; I-DemObs Group; Gasparini M (2018) Use of neuropsychological tests for the diagnosis of dementia: a survey of Italian memory clinics. BMJ Open 8(3):e017847. https://doi.org/10.1136/bmjopen-2017-017847. Canevelli M, Cova I, Remoli G, Bacigalupo I, Salvi E, Maestri G, Nicotra A, Valletta M, ImmiDem Study Network; ImmiDem Study Group et al (2022) A nationwide survey of Italian centers for cognitive disorders and dementia on the provision of care for international migrants. Eur J Neurol 29(7):1892–1902. https://doi.org/10.1111/ene.15297. Cook LD, Nichol KE, Isaacs JD (2019) The London memory service audit and quality improvement programme. BJPsych Bull 22:215–220. https://doi.org/10.1192/bjb.2019.18. Pink J, O'Brien J, Robinson L, Longson D (2018) Guideline committee. Dementia: assessment, management and support: summary of updated NICE guidance. BMJ. https://doi.org/10.1136/bmj.k2438. Chen Y, Lebouvier T, Skrobala E, Volpe-Gillot L, Huvent-Grelle D, Jourdan N, Leroy M, and the Meotis network et al (2020) Twenty-year trends in patient referrals throughout the creation and development of a regional memory clinic network. Alzheimers Dement (N Y) 6(1):e12048. https://doi.org/10.1002/trc2.12048. Rainero I, Bruni AC, Marra C, Cagnin A, Bonanni L, Cupidi C, Lagana V, Rubino E, SINdem COVID-19 Study Group et al (2021) The Impact of COVID-19 quarantine on patients with dementia and family caregivers: a nation- wide survey. Front Aging Neurosci 12:625781. https://doi.org/10.3389/fnagi.2020.625781. Zucca M, Isella V, Lorenzo RD, Marra C, Cagnin A, Cupidi C, Bonanni L, Lagano V, Rubino E, SINdem COVID-19 Study Group et al (2021) Being the family caregiver of a patient with dementia during the coronavirus disease 2019 lockdown. Front Aging Neurosci 13:653533. https://doi.org/10.3389/fnagi.2021.653533. Cascini S, Agabiti N, Marino C, Acampora A, Balducci M, Calandrini E, Davoli M, Bargagli AM (2022) Incidence and outcomes of SARS-CoV-2 infection in older adults living with dementia: a population-based cohort study. J Alzheimers Dis 89(2):681–693. https://doi.org/10.3233/JAD-220369. Cummings J, Rabinovici GD, Atri A, Aisen P, Apostolova LG, Hendrix S, Sabbagh M, Selkoe D, Weiner M, Salloway S (2022) Aducanumab: appropriate use recommendations update. J Prev Alzheimers Dis 9(2):221–230. https://doi.org/10.14283/jpad.2022.34. Gauthier S, Webster C, Servaes S, Morais JA, Rosa-Neto P (2022) World Alzheimer report 2022: life after diagnosis: navigating treatment, care and support. London, England: Alzheimer’s Disease International. https://www.alzint.org/u/World-Alzheimer-Report-2022.pdf. Accessed 26 April 2023 Religa D, Fereshtehnejad S-M, Cermakova P, Edlund AK, Garcia-Ptacek S, Granqvist N, Hallbäck A, Kåwe K et al (2015) SveDem, the Swedish dementia registry – a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLoS One 10:e0116538. https://doi.org/10.1371/journal.pone.011653. Geddes MR, O’Connell ME, Fisk JD, Gauthier S, Camicioli R, Ismail Z, Alzheimer society of Canada task force on dementia care best practices for COVID‐19 (2020) Remote cognitive and behavioral assessment: report of the Alzheimer society of Canada task force on dementia care best practices for COVID-19. Alzheimers Dement: Diagnosis, Assessment & Disease Monitoring 12(1):e12111. https://doi.org/10.1002/dad2.12111. Innovative care for chronic conditions: building blocks for actions (2002) https://www.who.int/publications/i/item/innovative-care-for-chronic-conditions-building-blocks-for-actions. Accessed 26 April 2023 Gervasi G, Bellomo G, Mayer F, Zaccaria V, Bacigalupo I, Lacorte E, Canevelli M, Corbo M, Di Fiandra T, Vanacore N (2020) Integrated care pathways on dementia in Italy: a survey testing the compliance with a national guidance. Neurol Sci 41(4):917–924. https://doi.org/10.1007/s10072-019-04184-9. Linee di indirizzo Nazionali sui Percorsi Diagnostico Terapeutici Assistenziali per le demenze (2017) https://www.salute.gov.it/imgs/C_17_pagineAree_4893_listaFile_itemName_0_file.pdf. Accessed 26 April 2023 Le Duff F, Develay AE, Quetel J, Lafay P, Schück S, Pradier C, Robert P, French National Alzheimer dataBank (BNA) (2012) The 2008–2012 French Alzheimer plan: description of the national Alzheimer information system. J Alzheimers Dis. 29(4):891–902. https://doi.org/10.3233/JAD-2012-111943. Bacigalupo I, Lombardo FL, Bargagli AM, Cascini S, Agabiti N, Davoli M, Scalmana S, Palma AD et al (2022) Identification of dementia and MCI cases in health information systems: an Italian validation study. Alzheimers Dement (N Y) 8(1):e12327. https://doi.org/10.1002/trc2.12327. Altomare D, Molinuevo JL, Ritchie C, Ribaldi F, Carrera E, DuboisB Jessen F, McWhirter L, European Task Force for Brain Health Services et al (2021) Brain health services: organization, structure, and challenges for implementation A user manual for Brain Health Services-part 1 of 6. Alzheimer Res Ther 13(1):168. https://doi.org/10.1186/s13195-021-00827-2. Frisoni GB, Altomare D, Ribaldi F, Villain N, Brayne C, Mukadam N, Abramowicz M, Barkhof F et al (2023) Dementia prevention in memory clinics: recommendations from the European task force for brain health services. Lancet Reg Health Eur 26:100576. https://doi.org/10.1016/j.lanepe.2022.100576. Filippi M, Cecchetti G, Cagnin A, Marra C, Nobili F, Parnetti L, Agosta F (2023) Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline. J Neurol Mar 9. https://doi.org/10.1007/s00415-023-11642-0. Ancidoni A, Lacorte E, Bacigalupo I, Lombardo F, Vanacore N (2023) Italy’s actions on dementia. Lancet Neurol 22(2):111. https://doi.org/10.1016/S1474-4422(22)00521-X.